Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Argatroban Action Pathway
Homo sapiens
Drug Action Pathway
Argatroban is a synthetic direct thrombin inhibitor it is recommended for people who have a risk for heparin-induced thrombocytopenia (HIT). The mechanism of action is done by inhibiting thrombin-catalyzed reactions like fibrin formation, it inhibits prothrombin so that fibrin cannot form stopping the formation of a clot. Argatroban is metabolized by the liver through hydroxylation and aromatization. Commonly administered through intravenous injection with a half-life of 30 - 60 minutes and is primarily excreted through the feces, bile and urine. It can interact with food products so it is best to avoid herbs and supplements with anticoagulant and antiplatelet activity such as garlic, ginger, bilberry, danshen, piracetam and ginkgo biloba. Extreme caution with grapefruit products as grapefruit inhibits CYP3A4 metabolism, this enzyme is responsible for metabolizing argatroban leading to increased concentration in the blood. Extreme caution should also be taken with St. John's Wort as it can interact with the drug.
References
Argatroban Pathway References
Kawada T, Okada Y, Hoson M, Endo S, Yokoyama M, Kitanaka Y, Kimura K, Abe H, Yamate N: Argatroban, an attractive anticoagulant, for left heart bypass with centrifugal pump for repair of traumatic aortic rupture. Jpn J Thorac Cardiovasc Surg. 1999 Mar;47(3):104-9. doi: 10.1007/BF03217952.
Pubmed: 10226408
Sakai M, Ohteki H, Narita Y, Naitoh K, Natsuaki M, Itoh T: Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model. Cardiovasc Surg. 1999 Mar;7(2):187-94. doi: 10.1016/s0967-2109(98)00119-7.
Pubmed: 10353669
Jang IK, Brown DF, Giugliano RP, Anderson HV, Losordo D, Nicolau JC, Dutra OP, Bazzino O, Viamonte VM, Norbady R, Liprandi AS, Massey TJ, Dinsmore R, Schwarz RP Jr: A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study. J Am Coll Cardiol. 1999 Jun;33(7):1879-85. doi: 10.1016/s0735-1097(99)00107-2.
Pubmed: 10362188
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings